Home » Topics » Regulatory

Regulatory
RSS

FDA approves Antagon for LH inhibition in women undergoing fertility treatment

July 30, 1999

Connetics seeks FDA approval of scalp dermatoses treatment

July 30, 1999

FDA approves SB's Kytril for prevention of radiation-induced nausea and vomiting

July 29, 1999

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

July 29, 1999

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

FDA approves pediatric formulation of Topamax

July 28, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

OraSolv Zomig receives first regulatory approval in Sweden for migraine

July 22, 1999

Tachykinin antagonists now proposed for attention deficit disorders

July 22, 1999

Use of zonisamide for neurodegenerative disorders

July 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...